Total expenditure on pharmaceuticals rose 8.74% to USD 338 mil in Estonia in 2017, according to OECD.
Historically, total expenditure on pharmaceuticals in Estonia reached an all time high of USD 338 mil in 2017 and an all time low of USD 60.6 mil in 1999.
Estonia has been ranked 28th within the group of 30 countries we follow in terms of total expenditure on pharmaceuticals, 5 places above the position seen 10 years ago.
Total Expenditure on Pharmaceuticals (USD) | Unit | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
Australia | USD mil | 11,386 | 10,142 | 9,475 | 11,124 | 11,091 | ... | |||||||||||||||
Belarus | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
China | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Estonia | USD mil | 307 | 321 | 304 | 311 | 338 | ||||||||||||||||
Finland | USD mil | 2,699 | 2,731 | 2,554 | 2,484 | 2,631 | ... | |||||||||||||||
Germany | USD mil | 41,848 | 43,265 | 40,522 | 38,723 | 41,757 | ... | |||||||||||||||
Indonesia | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Japan | USD mil | 70,503 | 58,550 | 56,155 | 55,827 | 58,523 | ... | |||||||||||||||
Latvia | USD mil | ... | ... | 408 | 407 | 380 | 396 | 441 | ||||||||||||||
Lithuania | USD mil | ... | ... | ... | ... | ... | 803 | ... | ... | ... | ... | ... | ... | |||||||||
New Zealand | USD mil | 756 | 769 | 720 | 741 | 888 | ||||||||||||||||
Papua New Guinea | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Russia | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
USA | USD mil | 326,988 | ... | ... | ... | ... | ... | ... |